Guest guest Posted March 15, 2008 Report Share Posted March 15, 2008 Info sent by NetRUMian Dr Rakesh Biswas, copied as fair use. Vijay Thawani -------------------------------------------- Dr Biswas I write to you in my role as Editor-in-Chief of Therapeutics and Clinical Risk Management (TCRM). I would like to invite you, or your colleagues, to submit an original research article, review, case report, or rapid communication to be considered by peer-review for publication in the Open Access section of TCRM in mid-2008. TCRM is an international, peer-reviewed, Open Access journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines. In order to meet publishing commitments we need to receive a draft manuscript from you by June 2008. Please let me know your response to this invitation, and do not hesitate to contact me if you have any comments or questions. Open Access papers appearing in TCRM are available via the Internet at no charge to readers. To recover our editorial and production costs we charge a publication processing fee. See http://www.dovepress.com/authors.php?content_id=700 for further details of the publication processing fee. We welcome Original Research Articles, Reviews, Case Reports, or Rapid Communications. If you'd like to submit a type of submission that falls outside one of these types, please discuss it with us. Journal home page available at: http://www.dovepress.com/articles.php?pa=overview & journal_id=68 Author guidelines are available at http://www.dovepress.com/authors.php Yours sincerely Professor Garry Walsh Editor-in-Chief Therapeutics and Clinical Risk Management Email: Ed@... Ps You can register to receive updates of new papers published in TCRM at http://www.dovepress.com/login.php Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.